ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,116.17
0.00%
Dow Jones
38,386.09
0.00%
US Dollar vs MXN
17.05578
0.24%
Brent Oil
87.175
-0.13%
Bitcoin
61,050.42
-4.36%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Assembly Biosciences Inc (ASMB)

  7. Assembly Biosciences Inc (ASMB) Noticias

ASMB Assembly Biosciences Inc

12.90
0.00 (0.00%)
Pre Mercado
Última actualización: 06:00:15
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Assembly Biosciences Inc ASMB NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 12.90 06:00:15
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
12.90
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
28/3/202415:05GLOBEAssembly Biosciences Reports Fourth Quarter and Year End..
08/2/202407:00GLOBEAssembly Biosciences Announces Effective Date of Reverse..
02/2/202415:05EDGAR2Form 8-K - Current report
19/1/202410:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202415:05EDGAR2Form 8-K - Current report
04/1/202407:00GLOBEAssembly Biosciences Provides Anticipated Development..
21/12/202315:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/12/202315:01EDGAR2Form DEF 14A - Other definitive proxy statements
11/12/202315:10EDGAR2Form PRE 14A - Other preliminary proxy statements
11/12/202315:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/12/202315:05EDGAR2Form 8-K - Current report
22/11/202315:12EDGAR2Form SC 13D/A - General statement of acquisition of..
22/11/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202315:05GLOBEAssembly Biosciences Reports Inducement Grant Under Nasdaq..
10/11/202307:00GLOBEAssembly Biosciences Presents New Data Highlighting Viral..
08/11/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202315:10EDGAR2Form 8-K - Current report
08/11/202315:05GLOBEAssembly Biosciences Reports Third Quarter 2023 Financial..
08/11/202307:00GLOBEAssembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief..
03/11/202315:05EDGAR2Form SC 13D/A - General statement of acquisition of..
31/10/202315:19EDGAR2Form SC 13D - General statement of acquisition of beneficial..
31/10/202311:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
17/10/202307:44DJNAssembly Biosciences Shares Soar Premarket on Gilead Pact
17/10/202306:51DJNGilead Taking Stake in Assembly Bio Under Antiviral..
17/10/202306:10EDGAR2Form 8-K - Current report
17/10/202306:00BWGilead and Assembly Biosciences Establish Partnership to..
11/10/202307:00GLOBEAssembly Biosciences to Present New Data at AASLD The Liver..
04/10/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202318:20EDGAR2Form 144 - Report of proposed sale of securities
03/10/202318:18EDGAR2Form 144 - Report of proposed sale of securities
02/10/202307:00GLOBEAssembly Biosciences Nominates Development Candidate..
19/9/202315:05GLOBEAssembly Biosciences to Highlight Pipeline Progress in HBV..
18/9/202317:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/8/202315:28EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/8/202315:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:12EDGAR2Form 8-K - Current report
09/8/202315:05GLOBEAssembly Biosciences Reports Second Quarter 2023 Financial..
07/8/202315:05EDGAR2Form 8-K - Current report
03/8/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202317:04EDGAR2Form 144 - Report of proposed sale of securities
02/8/202317:01EDGAR2Form 144 - Report of proposed sale of securities
25/7/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202307:00GLOBEAssembly Biosciences Presents New Data Highlighting Herpes..
21/6/202307:00GLOBEAssembly Biosciences Presents New Data Highlighting Entry..
07/6/202307:00GLOBEAssembly Biosciences to Present Data at Upcoming..
23/5/202315:05GLOBEAssembly Biosciences to Present During the 2023 Jefferies..
04/5/202315:05GLOBEAssembly Biosciences Reports First Quarter 2023 Financial..

Su Consulta Reciente

NASDAQ
ASMB
Assembly Biosciences
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados